The Group owns a number of wholly-owned and holding subsidiaries such as Rundu Mintong Pharmaceutical, Runtai Pharmaceutical, Meiyuanchun Pharmaceutical and Guangzhou Nanyang Polytechnic Vocational College. It has more than 3 national new drugs, among which Yitaiqing, a new drug for hypertension, and Tian Yu Qing, a new drug for digestive system, are national key new products, and Meiyuanchun is a well-known trademark in China.

Runtai Pharmaceutical Co., Ltd. is a new pharmaceutical enterprise under Rundu Group, which has passed the national GSP certification and is dominated by pharmaceutical marketing. Here, a group of elites from China pharmaceutical marketing industry are gathered. Based on the principle of high starting point and high standard, the company adopts flexible and innovative marketing strategies to establish a firm and orderly network marketing structure according to the different market conditions in different places. At present, the company mainly focuses on agent product marketing. In addition to products for treating liver diseases such as "Aoxing No.1 Oleanolic Acid Capsule", it is constantly introducing excellent pharmaceutical varieties at home and abroad, broadening sales channels and innovating sales models, and has established a set of industry forecasting and market feedback systems to promote a virtuous circle of efficient and orderly marketing business. It is a sales platform of Meiyuanchun Pharmaceutical Co., Ltd., which sells Meiyuanchun series drugs, health care products and foods and has passed the national GSP certification. The company has a perfect sales network in South China and East China, and through years of construction, it has an active, efficient and strong marketing team. The company's products occupy a very high market share in South China and East China, and are deeply loved by hundreds of millions of female consumers. Meiyuanchun brand also won the title of "China Famous Trademark" and "China Health Care Product Leader Brand". Meiyuanchun Medicine has always been committed to the cause of women's health, with the corporate mission of "being specialized, refined and strong", adhering to the "four modernizations" principle of "scientific development, marketization of operation, specialization of talents and standardization of system", actively innovating, advancing with the times, and striving to build the first brand of women's health care products in China.

Meiyuanchun Biotechnology Co., Ltd. is another sales platform of Meiyuanchun Pharmaceutical Co., Ltd., which mainly deals with Meiyuanchun series of women's nutrition products and cosmetics. There are dozens of products related to women's health, which have been unanimously welcomed by the majority of female consumers since its listing. It is one of the enterprises under Rundu Group, which integrates the research and development of new drugs, the production and sales of raw materials, intermediates and preparations.